These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 10561673)

  • 21. Prospective multicentre study comparing levonorgestrel implants with a combined contraceptive pill: final results.
    Kirkman RJ; Bromham DR; O'Connor TP; Sahota JE
    Br J Fam Plann; 1999 Jul; 25(2):36-40. PubMed ID: 10454652
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Leptin levels in patients with polycystic ovary syndrome in response to two different oral contraceptive treatments.
    Koyuncu FM; Kuscu NK; Var A; Onur E
    Acta Obstet Gynecol Scand; 2003 Aug; 82(8):767-8. PubMed ID: 12848650
    [No Abstract]   [Full Text] [Related]  

  • 23. Depot medroxyprogesterone acetate, oral contraceptives and bone mineral density in a cohort of adolescent girls.
    Cromer BA; Stager M; Bonny A; Lazebnik R; Rome E; Ziegler J; Debanne SM
    J Adolesc Health; 2004 Dec; 35(6):434-41. PubMed ID: 15581522
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Attitudes and experiences with levonorgestrel 100 microg/ethinyl estradiol 20 microg among women during a 3-month trial.
    Wimberly YH; Cotton S; Wanchick AM; Succop PA; Rosenthal SL
    Contraception; 2002 Jun; 65(6):403-6. PubMed ID: 12127637
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A 1-year study to compare the hemostatic effects of oral contraceptive containing 20 microg of ethinylestradiol and 100 microg of levonorgestrel with 30 microg of ethinylestradiol and 100 microg of levonorgestrel.
    Jespersen J; Endrikat J; Düsterberg B; Schmidt W; Gerlinger C; Wessel J; Sidelmann JJ; Skouby SO
    Contraception; 2005 Aug; 72(2):98-104. PubMed ID: 16022847
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ethinylestradiol + etonogestrel contraceptive vaginal ring: new drug. Possibly useful in some situations.
    Prescrire Int; 2006 Apr; 15(82):50-3. PubMed ID: 16604729
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Newer non-oral hormonal contraception.
    Bateson D; McNamee K; Briggs P
    BMJ; 2013 Feb; 346():f341. PubMed ID: 23412438
    [No Abstract]   [Full Text] [Related]  

  • 28. Efficacy of combined hormonal vaginal ring in comparison to combined hormonal pills in heavy menstrual bleeding.
    Dahiya P; Dalal M; Yadav A; Dahiya K; Jain S; Silan V
    Eur J Obstet Gynecol Reprod Biol; 2016 Aug; 203():147-51. PubMed ID: 27285306
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Low-dose ethinylestradiol/levonorgestrel.
    Dando TM; Curran MP
    Drugs; 2005; 65(16):2299-306; discusion 2307-8. PubMed ID: 16266199
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of ethinylestradiol and levonorgestrel on morphology, ultrastructure and histoenzymatic activity of rat kidney.
    Nowaczyk-Dura G; Czekaj P
    Physiol Res; 1998; 47(4):241-51. PubMed ID: 9803470
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Oestrogen treatment for increased bleeding in Norplant users: preliminary results.
    Witjaksono J; Lau TM; Affandi B; Rogers PA
    Hum Reprod; 1996 Oct; 11 Suppl 2():109-14. PubMed ID: 8982752
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Continuous oral contraceptives: are bleeding patterns dependent on the hormones given?
    Edelman AB; Koontz SL; Nichols MD; Jensen JT
    Obstet Gynecol; 2006 Mar; 107(3):657-65. PubMed ID: 16507938
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Oral contraceptives: 30 vs 20 micrograms of ethinyl estradiol (EE)].
    Urdinola J
    Adv Contracept; 1994 Jul; 10 Suppl 1():41-9. PubMed ID: 7839871
    [No Abstract]   [Full Text] [Related]  

  • 34. Quartette: an ascending-dose, extended-cycle oral contraceptive.
    Med Lett Drugs Ther; 2013 Jul; 55(1420):54-5. PubMed ID: 23836372
    [No Abstract]   [Full Text] [Related]  

  • 35. Effect of levonorgestrel implants on the periodontium.
    Kazerooni T; Ghaffarpasand F; Rastegar N; Kazerooni Y
    Int J Gynaecol Obstet; 2008 Dec; 103(3):255-6. PubMed ID: 18804758
    [No Abstract]   [Full Text] [Related]  

  • 36. Superior cycle control with a contraceptive vaginal ring compared with an oral contraceptive containing 30 microg ethinylestradiol and 150 microg levonorgestrel: a randomized trial.
    Oddsson K; Leifels-Fischer B; Wiel-Masson D; de Melo NR; Benedetto C; Verhoeven CH; Dieben TO
    Hum Reprod; 2005 Feb; 20(2):557-62. PubMed ID: 15539438
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The 150/30 formulation. Experience in the United Kingdom.
    Guillebaud J
    J Reprod Med; 1983 Jan; 28(1 Suppl):66-70. PubMed ID: 6403702
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The use of long-acting contraceptives in adolescents.
    Harel Z; Cromer B
    Pediatr Clin North Am; 1999 Aug; 46(4):719-32. PubMed ID: 10494253
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Low-dose contraceptive estrogen-progestin and coronary artery atherosclerosis of monkeys.
    Adams MR; Anthony MS; Manning JM; Golden DL; Parks JS
    Obstet Gynecol; 2000 Aug; 96(2):250-5. PubMed ID: 10908772
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of ticagrelor on the pharmacokinetics of ethinyl oestradiol and levonorgestrel in healthy volunteers.
    Butler K; Teng R
    Curr Med Res Opin; 2011 Aug; 27(8):1585-93. PubMed ID: 21692601
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.